Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartwatch exercise plan aims to rebuild fitness in young cancer survivors

NCT ID NCT07729059

Symptom relief Sponsor: Universität Duisburg-Essen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This trial tests whether a personalized, smartwatch-supported home exercise program can increase physical activity and improve heart health, mobility, and quality of life in adolescents and young adults who have survived bone or soft tissue sarcoma. Participants wear a fitness tracker and are randomly assigned to either receive an individualized exercise plan with online coaching or continue usual care. The study measures changes in daily activity, fitness, and well-being over an 8-week period.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
an individualized, partially supervised home-based exercise program supported by a smartwatch
What this could lead to
If it works, this could point toward a standard exercise support program to improve long-term health and quality of life for young sarcoma survivors.
What could go wrong
This is a small, early-stage trial with only 46 participants, so results may not apply to all survivors. The exercise program requires motivation and access to a smartphone, which may limit participation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 46 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of bone or soft tissue sarcoma * Currently receiving follow-up care at the tumor orthopedics clinic of University Hospital Essen * Age ≥15 and ≤39 years at time of enrollment * Completion of local tumor therapy (surgery and/or definitive radiotherapy) more than 12 months prior to enrollment * Access to a smartphone for data synchronization with the wearable device Exclusion Criteria: * Contraindications to physical activity * Language barriers preventing communication in German * Known or current psychiatric condition impairing the ability to understand study requirements, participate in the study, or provide informed consent * Pregnancy * Planned absence of more than 2 weeks during the study period (e.g., due to rehabilitation stays) * Pre-existing average MVPA \>60 minutes/day at baseline

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bone sarcoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

bone cancer bone sarcoma Motor Activity sarcoma soft tissue sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bone sarcoma Soft tissue sarcoma (STS)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.